Ftse Mib
34.271,12
-0,27%
DAX
18.088,70
-0,30%
S&P 500
5.071,63
0,02%
NASDAQ Composite
15.712,75
0,10%
Bitcoin
63.903,27
-3,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni Regno Unito LSE Johnson & Johnson (0R34) Johnson & Johnson (0R34) Notizie

Johnson & Johnson

0R34
149,60
0,00 (0,00%)
24 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202412:54ALNCNewsTOP NEWS: Johnson & Johnson upgrades guidance on swing to..
05/4/202413:02ALNCNewsTOP NEWS: J&J swoops for Shockwave Medical in USD13.1..
25/3/202419:28ALNCNewsIN BRIEF: J&J submits US premarket approval application for..
18/3/202412:10ALNCNewsIN BRIEF: Johnson & Johnson receives FDA recommendation for..
23/2/202419:32ALNCNewsIN BRIEF: Johnson & Johnson gets EMA nod for Carvykti in..
02/2/202407:22ALNCNewsTOP NEWS: US sends drugmakers initial offers in Medicare..
23/1/202412:41ALNCNewsTOP NEWS: Johnson & Johnson eyes future growth; 2023 sales..
19/1/202422:34ALNCNewsIN BRIEF: J&J gets US FDA approval for cancer treatment..
05/12/202314:24ALNCNewsTOP NEWS: J&J expects strong long-term growth in three key..
23/10/202313:03ALNCNewsJ&J report slew of positive trial results focused on various..
17/10/202312:46ALNCNewsTOP NEWS: J&J raises full-year sales outlook after "solid"..
06/10/202317:52ALNCNewsIN BRIEF: J&J applies for indication extension to EMA for..
03/10/202318:00ALNCNewsDrugmakers agree to US government price talks amid pushback
07/9/202307:50ALNCNewsJ&J's Janssen ends Phase 3 MACiTEPH study evaluating..
30/8/202318:07ALNCNewsTOP NEWS: J&J forecasts strong growth in earnings after..
10/8/202322:34ALNCNewsIN BRIEF: Johnson & Johnson's blood cancer therapy approved..
20/7/202313:30ALNCNewsTOP NEWS: J&J ups full-year guidance after "robust" second..
30/5/202317:48ALNCNewsJ&J seeks FDA approval for pulmonary arterial hypertension..
09/5/202321:23ALNCNewsJ&J says Tremfya data shows positive results for ulcerative..
04/5/202313:41ALNCNewsIN BRIEF: J&J prices subsidiary Kenvue's NYSE initial public..
01/5/202308:51ALNCNewsJohnson & Johnson reports first results from TAR-200 study
Apertura: Min: Max:
Chiusura: 149,60

La tua Cronologia

LSE
0R34
Johnson & Johnson
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network